A Phase 1 Open Label, Multi-Arm, Multicenter Study of MK-1308 in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors.

  • Voskoboynik, Mark (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann, (Project Manager)

Project: Research

StatusActive
Effective start/end date7/08/1931/12/24

Keywords

  • Medical Oncology
  • Solid Tumors
  • Clinical trial
  • Medical Oncology
  • Solid Tumors
  • Clinical trial
  • Medical Oncology
  • Solid Tumors
  • Clinical trial